Company news
Exagen Inc. news in 2021
Exagen Inc.'s news releases, calls and decks from 2021, newest first.
Exagen Inc. to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 16, 2021
Exagen Inc. Reports Third Quarter 2021 Results
November 9, 2021
Exagen Inc. to Participate in the 2021 Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health and Services Forum
November 3, 2021
Exagen to Announce Third Quarter 2021 Financial Results on November 10, 2021
October 26, 2021
Exagen Inc. Expands Coverage with Inland Empire Health Plan, Partnering to Provide More Accurate Diagnostic Testing with AVISE® CTD and AVISE Lupus
October 26, 2021
Exagen Inc. Announces $27.2 Million Debt Refinancing
October 24, 2021
Exagen Showcases Eight Scientific Presentations at ACR’s Virtual Annual Meeting in November 2021
October 20, 2021
Exagen Inc. to Participate in the 2021 Cantor Fitzgerald Virtual Global Healthcare Conference
September 12, 2021
Exagen Inc. Reports Second Quarter 2021 Results
August 8, 2021
Exagen Appoints Ana Hooker to Board of Directors
July 29, 2021
Exagen Inc. to Participate in the Canaccord Genuity 41st Annual Growth Conference
July 28, 2021
Exagen to Announce Second Quarter 2021 Financial Results on August 9, 2021
July 25, 2021
Exagen Elects Frank Stokes to Board of Directors
June 17, 2021
Exagen Inc. Reports First Quarter 2021 Results
May 10, 2021
Exagen Inc., Allegheny Health Network Research Institute and AHN Autoimmunity Institute Announce Collaboration to Develop Novel Patented Biomarkers into Clinical Diagnostic Tests
May 3, 2021
Exagen Announces New Campaign and Initiatives for Lupus Awareness Month
May 2, 2021
Exagen to Announce First Quarter 2021 Financial Results on May 11, 2021
April 26, 2021
Exagen Inc. Announces Study on the Long-Term Effects of COVID-19 Infection in the Development of Autoimmune Diseases
March 28, 2021
Exagen Inc. Announces Closing of Public Offering of Common Stock, Including Full Exercise of Underwriters’ Option to Purchase Additional Shares
March 24, 2021
Exagen Inc. Announces Pricing of Public Offering of Common Stock
March 21, 2021
Exagen Inc. Reports Fourth Quarter and Full Year 2020 Results
March 15, 2021
Exagen to Announce Fourth Quarter and Full Year Financial Results on March 16, 2021
March 1, 2021
Exagen Inc. Partners with Boston’s Tufts Medical Center to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
January 20, 2021
Exagen Inc. Reports Preliminary Fourth Quarter 2020 Testing Results
January 9, 2021
Exagen Inc. Partners with Oregon’s St. Charles Health System to Offer AVISE® Testing as an In-Network Benefit for Patients Suffering from Debilitating Autoimmune Diseases
January 3, 2021